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Neurofibromatosis type-1 (NF-1) is an autosomal dominant genetic condition caused by mutation in the neurofibromin gene. Classic symptoms include neurofibromas, hyperpigmented cutaneous spots (café-au-lait macules), axillary and/or inguinal freckling, iris hamartomas (Lisch nodules), and bone lesions [@bib1]. Rarely, patients with NF-1 can have vascular abnormalities such as aneurysms, stenoses, and arteriovenous malformations. The exact pathogenesis of these abnormalities is unknown, but is thought to be due to alteration of neurofibromin expression in endothelial and smooth muscle cells of blood vessels [@bib2]. Most patients remain asymptomatic. The most common site of involvement was reported to be the renal artery, which leads to renal artery hypertension [@bib2].

We report a case of a 30-year-old female with NF-1 who presented with a spontaneous rupture of a vertebral artery (VA) aneurysm. A review of the literature by Oderich et al. found 46 reports of carotid, vertebral, and cerebral aneurysms, and noted that they occur most commonly in the third decade of life and are more frequent in women [@bib3]. However, extracranial vertebral artery aneurysm in neurofibromatosis type 1 is very rare. Our review of the literature reveals 24 cases of extradural vertebral artery aneurysms in patients with NF-1, 12 of which ruptured and caused hemorrhage \[[@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24]\] ([Table 1](#tbl1){ref-type="table"}).Table 1Cases of Vertebral Artery Aneurysm in association with NF-1.Table 1Case NumberAuthor/YearAge (years)/GenderRuptured or UnrupturedSide/Level/AVFTreatmentSymptomsOutcome1Uneda et al. [@bib4]/201635/FRupturedR/C3--C4/AVFEndovascular (coil)Neck and shoulder painRecovery2Pentecost et al. [@bib34]/19811/FUnrupturedL/Th1/NoObservationLimited range of motion, weaknessDisabled3Schubiger and Yasargil [@bib24]/197850/MUnrupturedL/C2--C6/NoSurgeryRadiculopathyRecovery4Detwiler et al. [@bib23]/198752/FUnrupturedL/C2/NoEndovascular (balloon)Neck mass, pain, bruitsRecovery5Negoro et al. [@bib7]/199047/FRupturedL/C1/NoEndovascular (balloon)Neck pain, cervical hematomaRecovery6Muhonen et al. [@bib22]/199152/FUnrupturedL/C2/NoEndovascular (balloon)Neck mass and pain, arm weaknessRecovery7Schievink and Piepgras [@bib21]/199143/FUnrupturedL/C7/NoObservationNoneRecovery8Ohkata et al. [@bib20]/199448/FUnrupturedL/C4--C7/NoSurgeryRadiculopathyRecovery9Horsley et al. [@bib11]/199756/FRupturedL/C5--C7/NoEndovascular (coil)Neck pain and mass, arm parasthesiasRecovery10Hoffmann et al. [@bib13]/199859/MUnrupturedR/C6/NoObservationNoneRecovery11Ushikoshi et al. [@bib19]/199940/FRupturedL/C1/AVF (secondary)Endovascular (balloon)Occipitalgia, cervical hematomaRecovery12Miyazaki et al. [@bib9]/200452/FRupturedL/C5--C7/NoEndovascular (balloon), surgeryhemothorax, radiculopathy, hypotension, altered mental statusDeath13Arai et al. [@bib17]/200738/MRupturedL/-/NoNoneAngina, dizziness, vomiting, hemothoraxDeath14Hieda et al. [@bib28]/200736/FRupturedL/-/NoEndovascular (coil, n-butyl cyanoacrylate)Back pain, angina, dyspnea, hypotension, hemothorax, comaDeath15Hiramatsu et al. [@bib14]/200767/MUnrupturedL/proximal vertebral artery/NoEndovascular (coil)DizzinessRecovery16Pereira et al. [@bib18]/200714/FUnrupturedR/C5--C6/NoEndovascular (balloon)RadiculopathyRecovery17Peyre et al. [@bib6] 200718/FUnrupturedR/C5--C6/NoEndovascular (coil)RadiculopathyRecovery18Horie et al. [@bib12]/200830/FUnrupturedR/C6--C7/NoEndovascular (coil, balloon)RadiculopathyRecovery19Higa et al. [@bib27]/201060/FRupturedL/-/NoEndovascular (coil)Cervical hematoma, stridor, respiratory failureDisabled20Morvan et al. [@bib8]/201136/FRupturedL/C3--C4/NoEndovascular (coil, stent)Head and neck pain, vomiting, subarachnoid hemorrhage--21Hiramatsu et al. [@bib15]/201231/MRupturedR/C6/NoEndovascular (coil)Radiculopathy, neck pain, cervical hematomaRecovery22Gouaillier-Vulcain F et al. [@bib16]/201432/MUnrupturedL/C8/NoSurgery, endovascular (stent)RadiculopathyRecovery23CY Lin et al. [@bib10]/201718/FRupturedL/proximal/NoEndovascular (coil, stent)Seizures, neck swellingRecovery
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This is a 30-year-old female with a past medical history of neurofibromatosis type 1, anterior cervical discectomy and fusion (ACDF) and solid posterior fusion of most of the cervical spine due to kyphosis, a large syrinx in the spinal cord, and hydrocephalus, status-post ventriculoperitoneal (VP) shunt in 2001, who presented to the emergency department (ED) with altered mental status. Per her family, the patient started complaining of headache and sudden onset right neck and chest pain, and subsequently fell to the ground. Since then, the patient experienced generalized pain and had become increasingly lethargic. She had cough and nasal congestion for the past week but had otherwise been well until the onset of these symptoms. The patient\'s history is notable for VP shunt malfunction in 2013. Upon arrival to the ED, the patient was found to be extremely hypotensive and hypothermic, with a blood pressure range of (65--95)/(37--60), and a temperature of 92.1 F (33.4 C). She was intubated in the ED, was unresponsive to 4 L of IV fluids, and was started on pressors for the hypotension. On physical exam, the patient was lethargic and in significant distress secondary to pain. She opened her eyes to pain, followed commands, and moved all extremities purposefully. Her pupils were equal, round, and reactive to light, and extraocular movements were intact. Severe nuchal rigidity was noted. Her shunt depressed and refilled on examination. Abdomen was soft and nontender. Labs were obtained, and her electrolytes were found to be within normal limits, hemoglobin was 11.2 g/dL, and white blood count was 12.1. Her partial thromboplastin time (PTT) and international normalized ratio (INR) were normal at 30.0 and 1.16, respectively.

The patient had a computerized tomography (CT) study which revealed a right vertebral artery (VA) aneurysm and right hemothorax ([Fig. 1](#fig1){ref-type="fig"}). A chest tube was placed. CT soft tissue of the neck with contrast showed soft tissue prominence in the right supraclavicular region with a blush of contrast posteriorly suggestive of evolving hematoma with arterial extravasation ([Fig. 2](#fig2){ref-type="fig"}). There were some delays in the proper assessment of the patient\'s status and severity of their condition, possibly due to lack of effective communication. Patient was eventually taken for a cerebral angiogram on hospital day two. Coil embolization was performed of the right VA/V1 segment pseudoaneurysm with therapeutic right VA sacrifice ([Fig. 3](#fig3){ref-type="fig"}). Patient received 2 units of packed red blood cells intraoperatively. The patient continued to have symptoms of airway obstruction and was taken to the operating room on hospital day seven to address the right neck hematoma and facilitate intra-operative extubation. The procedure revealed copious amounts of blood with large clots which were evacuated from the right posterior lateral neck and supraclavicular region that had been causing tracheal deviation to the left. Extubation was successful, and a surgical drain was placed in the right paramedian supraclavicular region. The patient was then transferred to the surgical intensive care unit for medical management. The patient was discharged home after stabilization and was back to baseline. She followed up at clinic for the subsequent months. Unfortunately, she died of an unrelated accidental traumatic brain injury shortly after her hospitalization.Fig. 1CT of chest showing large right pleural effusion with layering hyperdensity compatible with hemothorax.Fig. 1Fig. 2CT soft tissue neck with contrast demonstrating soft tissue prominence in the right supraclavicular region with a blush of contrast posteriorly suggestive of evolving hematoma with arterial extravasation.Fig. 2Fig. 3CT Neck status post coiling and hematoma evacuation, revealing embolic coil material in the proximal right vertebral artery. Hematoma decreased in size from [Fig. 1](#fig1){ref-type="fig"} with decrease in degree of tracheal deviation.Fig. 3
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NF-1, a well-described neurocutaneous condition, is known for the ubiquitous effects on the nervous system as well as other organ systems and renders patients more susceptible to numerous complications such as tumors and vascular pathologies [@bib25]. This is similar to the increased risk for developing cerebrovascular diseases notable in patients with certain connective tissue disorders such as Marfan syndrome, Ehler-Danlos sydrome, and Loeys-Dietz syndrome [@bib26]. These disorders, in addition to NF-1, are linked to vasculopathies including arterial aneurysms because of their involvement of components of the extracellular matrix, which compromises the integrity of vessel walls.

Routine screening for these vasculopathies is not recommended, due to their rare incidence. When aneurysms are discovered incidentally on imaging, a decision must be made to pursue operative treatment versus conservative management. Large aneurysms are more likely to undergo open reconstruction, as endovascular treatment has not yet been standardized for aortic or renovascular aneurysms [@bib3]. Lesions affecting the abdominal aorta or the renal artery causing claudication or renovascular hypertension, respectively, may prompt operative intervention.

Vertebral artery aneurysms can present with various symptoms and findings [@bib3], including neck pain; neck mass; respiratory compromise due to mass effect of aneurysms or hematomas; upper extremity neurologic symptoms due to compression of the brachial plexus; neurologic symptoms related to the VA territory; and bony erosion of the vertebrae [@bib3].

Vertebral artery aneurysm rupture can be a fatal condition if not recognized promptly and managed aggressively, especially when the patient presents in hemorrhagic shock. Management options include surgical or endovascular treatment, or observation. Surgical treatment carries a higher risk of exsanguination, and observation in many cases results in death \[[@bib17], [@bib27]\]. Operative treatment with endovascular coiling is necessary for prevention of further complication and potentially fatal hemorrhage, as this method of treatment in minimally invasive and shorter in duration. Very rarely, the aneurysm can hemorrhage into the thoracic cavity, leading to hemothorax [@bib28]. Hemorrhagic shock due to hemothorax in NF-1 patients can alternatively be caused by hemorrhagic mediastinal tumors or erosion of thoracic vessels by a tumor \[[@bib29], [@bib30], [@bib31]\], but when an aneurysm is identified in patients with hemothorax, intervention becomes necessary after hemodynamic stabilization [@bib29]. It is important to note that a variety of aneurysms have been reported with different arterial origins causing intrathoracic hemorrhage, and various arteries have been identified as sources of bleeding, such as intercostal and subclavian arteries, often secondary to enlarging tumors \[[@bib29], [@bib32]\].

In patients with airway compromise, early evacuation of resultant hematomas in the laterocervical compartment and surgical drainage is necessary, which can also be seen in the case report by Bissacco et al. [@bib33] As such, extra caution should be taken when a patient with NF-1 presents acutely with complaints of neck pain and/or symptoms of hemorrhage or shock \[[@bib3], [@bib34]\]. In the cases of patients who are diagnosed with an aneurysm that has not ruptured yet, it critical to serially monitor these vessels and assess for progression and intervene as needed [@bib35].
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